GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tecan Group AG (FRA:TEN) » Definitions » Debt-to-EBITDA

Tecan Group AG (FRA:TEN) Debt-to-EBITDA : 1.44 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Tecan Group AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tecan Group AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €13 Mil. Tecan Group AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €322 Mil. Tecan Group AG's annualized EBITDA for the quarter that ended in Dec. 2023 was €233 Mil. Tecan Group AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.44.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Tecan Group AG's Debt-to-EBITDA or its related term are showing as below:

FRA:TEN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.02   Med: 0.19   Max: 1.56
Current: 1.54

During the past 13 years, the highest Debt-to-EBITDA Ratio of Tecan Group AG was 1.56. The lowest was 0.02. And the median was 0.19.

FRA:TEN's Debt-to-EBITDA is ranked worse than
54.25% of 435 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs FRA:TEN: 1.54

Tecan Group AG Debt-to-EBITDA Historical Data

The historical data trend for Tecan Group AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecan Group AG Debt-to-EBITDA Chart

Tecan Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.25 1.56 1.46 1.54

Tecan Group AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.36 1.58 1.56 1.44

Competitive Comparison of Tecan Group AG's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Tecan Group AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tecan Group AG's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tecan Group AG's Debt-to-EBITDA falls into.



Tecan Group AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tecan Group AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.979 + 322.195) / 218.362
=1.53

Tecan Group AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.979 + 322.195) / 232.6
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Tecan Group AG  (FRA:TEN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Tecan Group AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tecan Group AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecan Group AG (FRA:TEN) Business Description

Traded in Other Exchanges
Address
Seestrasse 103, Mannedorf, CHE, 8708
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life science research markets. The firm operates in two segments; Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, and Partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their own names. A majority proportion of Tecan's revenue is generated in the Americas and Europe.